Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 9 de 9
1.
ACS Chem Neurosci ; 15(9): 1770-1786, 2024 May 01.
Article En | MEDLINE | ID: mdl-38637513

Parkinson's disease arises from protein misfolding, aggregation, and fibrillation and is characterized by LB (Lewy body) deposits, which contain the protein α-synuclein (α-syn) as their major component. Another synuclein, γ-synuclein (γ-syn), coexists with α-syn in Lewy bodies and is also implicated in various types of cancers, especially breast cancer. It is known to seed α-syn fibrillation after its oxidation at methionine residue, thereby contributing in synucleinopathy. Despite its involvement in synucleinopathy, the search for small molecule inhibitors and modulators of γ-syn fibrillation remains largely unexplored. This work reveals the modulatory properties of cyclic-nordihydroguaiaretic acid (cNDGA), a natural polyphenol, on the structural and aggregational properties of human γ-syn employing various biophysical and structural tools, namely, thioflavin T (ThT) fluorescence, Rayleigh light scattering, 8-anilinonaphthalene-1-sulfonic acid binding, far-UV circular dichroism (CD), Fourier transform infrared spectroscopy (FTIR) spectroscopy, atomic force microscopy, ITC, molecular docking, and MTT-toxicity assay. cNDGA was observed to modulate the fibrillation of γ-syn to form off-pathway amorphous species that are nontoxic in nature at as low as 75 µM concentration. The modulation is dependent on oxidizing conditions, with cNDGA weakly interacting (Kd ∼10-5 M) with the residues at the N-terminal of γ-syn protein as investigated by isothermal titration calorimetry and molecular docking, respectively. Increasing cNDGA concentration results in an increased recovery of monomeric γ-syn as shown by sodium dodecyl sulfate and native-polyacrylamide gel electrophoresis. The retention of native structural properties of γ-syn in the presence of cNDGA was further confirmed by far-UV CD and FTIR. In addition, cNDGA is most effective in suppression of fibrillation when added at the beginning of the fibrillation kinetics and is also capable of disintegrating the preformed mature fibrils. These findings could, therefore, pave the ways for further exploring cNDGA as a potential therapeutic against γ-synucleinopathies.


Masoprocol , gamma-Synuclein , Humans , gamma-Synuclein/metabolism , Masoprocol/pharmacology , Protein Aggregates/drug effects , Protein Aggregates/physiology , Spectroscopy, Fourier Transform Infrared , Protein Aggregation, Pathological/metabolism , Protein Aggregation, Pathological/drug therapy
2.
Microb Pathog ; 149: 104279, 2020 Dec.
Article En | MEDLINE | ID: mdl-32512154

Bacitracin has well familiar effects on growth and colonization of bacteria but its antibiofilm action on majority of bacteria is still not studied. Bacitracin is a bactericidal antibiotic that primarily acts on Gram positive bacteria by obstructing the process of cell wall synthesis. In this study, we have investigated antibiofilm potential and the mechanism of bacitracin against a cariogenic bacteria 'Streptococcus mutans' which has not been reported so far. Bacitracin has been found to affect propensity of S. mutans to form biofilm. On treatment with sub-MIC concentration of bacitracin resulted in significant reduction in bifilm formation as evaluated by crystal violet and congo red assays. The architecture of S. mutans biofilm was observed by scanning electron microscopy which revealed astonishing phenotype of biofilm. Deficient biofilm was found to be composed of abnormally elongated cells. Transmission electron microscopy showed multiple septa formation in each cell of biofilm thereby indicating, cell division defect as the most probable cause of cell elongation. To elucidate the effect of bacitracin on molecular level, expression profiling of genes critically important for cell division and biofilm formation was performed, which were found many folds downregulated. Bacitracin at very low concentration has been found to have potent antibiofilm activity, therefore is a potential antibiofilm agent to treat oral biofilms. It is being anticipated, this study will offer novel information to identify potential targets and effectively creates true innovation to understand the biofilm's basic biology. Besides, discovering new uses for currently marketed drugs makes commercial as well as research sense.


Bacitracin , Streptococcus mutans , Anti-Bacterial Agents/pharmacology , Bacitracin/pharmacology , Biofilms , Microbial Sensitivity Tests
3.
Sci Rep ; 9(1): 15012, 2019 Oct 15.
Article En | MEDLINE | ID: mdl-31611603

A correction to this article has been published and is linked from the HTML and PDF versions of this paper. The error has not been fixed in the paper.

4.
Sci Rep ; 9(1): 8508, 2019 06 11.
Article En | MEDLINE | ID: mdl-31186458

Glycosylphosphatidylinositol (GPI)-anchored proteins are important for virulence of many pathogenic organisms including the human fungal pathogen, Candida albicans. GPI biosynthesis is initiated by a multi-subunit enzyme, GPI-N-acetylglucosaminyltransferase (GPI-GnT). We showed previously that two GPI-GnT subunits, encoded by CaGPI2 and CaGPI19, are mutually repressive. CaGPI19 also co-regulates CaERG11, the target of azoles while CaGPI2 controls Ras signaling and hyphal morphogenesis. Here, we investigated the role of a third subunit. We show that CaGpi15 is functionally homologous to Saccharomyces cerevisiae Gpi15. CaGPI15 is a master activator of CaGPI2 and CaGPI19. Hence, CaGPI15 mutants are azole-sensitive and hypofilamentous. Altering CaGPI19 or CaGPI2 expression in CaGPI15 mutant can elicit alterations in azole sensitivity via CaERG11 expression or hyphal morphogenesis, respectively. Thus, CaGPI2 and CaGPI19 function downstream of CaGPI15. One mode of regulation is via H3 acetylation of the respective GPI-GnT gene promoters by Rtt109. Azole sensitivity of GPI-GnT mutants is also due to decreased H3 acetylation at the CaERG11 promoter by Rtt109. Using double heterozygous mutants, we also show that CaGPI2 and CaGPI19 can independently activate CaGPI15. CaGPI15 mutant is more susceptible to killing by macrophages and epithelial cells and has reduced ability to damage either of these cell lines relative to the wild type strain, suggesting that it is attenuated in virulence.


Azoles/pharmacology , Biosynthetic Pathways , Candida albicans/enzymology , Fungal Proteins/metabolism , Glycosylphosphatidylinositols/metabolism , Protein Subunits/metabolism , Animals , Biosynthetic Pathways/drug effects , Candida albicans/drug effects , Candida albicans/genetics , Candida albicans/growth & development , Cell Line , Cell Wall/drug effects , Cell Wall/metabolism , Chromosomes, Fungal/genetics , Epithelial Cells/drug effects , Epithelial Cells/microbiology , Ergosterol/biosynthesis , Fungal Proteins/genetics , Gene Expression Regulation, Fungal/drug effects , Genes, Fungal , Heterozygote , Hyphae/drug effects , Macrophages/drug effects , Macrophages/metabolism , Mice , Mutation/genetics , Phagocytosis/drug effects , Phenotype , Protein Subunits/genetics , Saccharomyces cerevisiae/metabolism , Signal Transduction/drug effects , Virulence/drug effects
5.
IUBMB Life ; 70(5): 355-383, 2018 05.
Article En | MEDLINE | ID: mdl-29679465

Glycosylphosphatidylinositol (GPI)-anchored proteins (GPI-APs) are present ubiquitously at the cell surface in all eukaryotes. They play a crucial role in the interaction of the cell with its external environment, allowing the cell to receive signals, respond to challenges, and mediate adhesion. In yeast and fungi, they also participate in the structural integrity of the cell wall and are often essential for survival. Roughly four decades after the discovery of the first GPI-APs, this review provides an overview of the insights gained from studies of the GPI biosynthetic pathway and the future challenges in the field. In particular, we focus on the biosynthetic pathway in Saccharomyces cerevisiae, which has for long been studied as a model organism. Where available, we also provide information about the GPI biosynthetic steps in other yeast/ fungi. Although the core structure of the GPI anchor is conserved across organisms, several variations are built into the biosynthetic pathway. The present Review specifically highlights these variations and their implications. There is growing evidence to suggest that several phenotypes are common to GPI deficiency and should be expected in GPI biosynthetic mutants. However, it appears that several phenotypes are unique to a specific step in the pathway and may even be species-specific. These could suggest the points at which the GPI biosynthetic pathway intersects with other important cellular pathways and could be points of regulation. They could be of particular significance in the study of pathogenic fungi and in identification of new and specific antifungal drugs/ drug targets. © 2018 IUBMB Life, 70(5):355-383, 2018.


Candida albicans/metabolism , Fungal Proteins/metabolism , Glycosylphosphatidylinositols/biosynthesis , Lipid-Linked Proteins/metabolism , Saccharomyces cerevisiae/metabolism , Antifungal Agents/pharmacology , Candida albicans/drug effects , Candida albicans/genetics , Carbohydrate Sequence , Fungal Proteins/chemistry , Fungal Proteins/genetics , Gene Expression Regulation, Fungal , Glycosylphosphatidylinositols/chemistry , Glycosylphosphatidylinositols/deficiency , Glycosylphosphatidylinositols/genetics , Glycosylphosphatidylinositols/metabolism , Humans , Lipid-Linked Proteins/chemistry , Lipid-Linked Proteins/genetics , Metabolic Diseases/genetics , Metabolic Diseases/metabolism , Metabolic Diseases/pathology , Mutation , Phenotype , Saccharomyces cerevisiae/drug effects , Saccharomyces cerevisiae/genetics , Seizures/genetics , Seizures/metabolism , Seizures/pathology , Signal Transduction , Species Specificity
6.
Sci Rep ; 8(1): 5248, 2018 03 27.
Article En | MEDLINE | ID: mdl-29588468

Ras signaling in response to environmental cues is critical for cellular morphogenesis in eukaryotes. This signaling is tightly regulated and its activation involves multiple players. Sometimes Ras signaling may be hyperactivated. In C. albicans, a human pathogenic fungus, we demonstrate that dynamics of hyperactivated Ras1 (Ras1G13V or Ras1 in Hsp90 deficient strains) can be reliably differentiated from that of normal Ras1 at (near) single molecule level using fluorescence correlation spectroscopy (FCS). Ras1 hyperactivation results in significantly slower dynamics due to actin polymerization. Activating actin polymerization by jasplakinolide can produce hyperactivated Ras1 dynamics. In a sterol-deficient hyperfilamentous GPI mutant of C. albicans too, Ras1 hyperactivation results from Hsp90 downregulation and causes actin polymerization. Hyperactivated Ras1 co-localizes with G-actin at the plasma membrane rather than with F-actin. Depolymerizing actin with cytochalasin D results in faster Ras1 dynamics in these and other strains that show Ras1 hyperactivation. Further, ergosterol does not influence Ras1 dynamics.


Candida albicans/metabolism , Candidiasis/microbiology , Fungal Proteins/metabolism , Signal Transduction , ras Proteins/metabolism , Actins/analysis , Actins/metabolism , Candida albicans/cytology , Candida albicans/genetics , Candida albicans/growth & development , Cytochalasin D/analysis , Cytochalasin D/metabolism , Ergosterol/metabolism , Fungal Proteins/analysis , Fungal Proteins/genetics , HSP90 Heat-Shock Proteins/analysis , HSP90 Heat-Shock Proteins/metabolism , Humans , Hyphae/genetics , Hyphae/growth & development , Hyphae/metabolism , Morphogenesis , Up-Regulation , ras Proteins/analysis , ras Proteins/genetics
7.
Bio Protoc ; 7(11): e2303, 2017 Jun 05.
Article En | MEDLINE | ID: mdl-34541072

In this protocol we describe a nonradiolabelled labelling of GPI anchor in Candida albicans. The method uses a fluorescent probe to bind specifically to GPI anchors so that the level of GPI-anchored proteins at the cell surface can be measured. The labelling does not need permeabilization of cells and can be carried out in vivo.

8.
Yeast ; 33(8): 365-83, 2016 08.
Article En | MEDLINE | ID: mdl-27337589

CaGpi14 is the catalytic subunit of the first mannosyltransferase that is involved in the glycosylphosphatidylinositol (GPI) biosynthetic pathway in Candida albicans. We show that CaGPI14 is able to rescue a conditionally lethal gpi14 mutant of Saccharomyces cerevisiae, unlike its mammalian homologue. The depletion of this enzyme in C. albicans leads to severe growth defects, besides causing deficiencies in GPI anchor levels. In addition, CaGpi14 depletion results in cell wall defects and upregulation of the cell wall integrity response pathway. This in turn appears to trigger the osmotic-stress dependent activation of the HOG1 pathway and an upregulation of HOG1 as well as its downstream target, SKO1, a known suppressor of expression of hyphae-specific genes. Consistent with this, mutants of CaGPI14 are unable to undergo hyphal transformations in different hyphae-inducing media, under conditions that produce abundant hyphae in the wild-type cells. Hyphal defects in the CaGPI14 mutants could not be attributed either to reduced protein kinase C activation or to defective Ras signalling in these cells but appeared to be driven by perturbations in the HOG1 pathway. Copyright © 2016 John Wiley & Sons, Ltd.


Candida albicans/growth & development , Catalytic Domain , Cell Wall/metabolism , Glycosylphosphatidylinositols/biosynthesis , Hyphae/growth & development , Mannosyltransferases/metabolism , Basic-Leucine Zipper Transcription Factors/genetics , Candida albicans/enzymology , Candida albicans/genetics , Genes, Lethal , Hyphae/enzymology , Hyphae/genetics , Mannosyltransferases/chemistry , Mannosyltransferases/genetics , Mitogen-Activated Protein Kinases/genetics , Morphogenesis , Mutation , Osmotic Pressure , Protein Kinase C/metabolism , Repressor Proteins/genetics , Saccharomyces cerevisiae/genetics , Saccharomyces cerevisiae Proteins/genetics , Spectrometry, Mass, Electrospray Ionization
9.
Glycoconj J ; 31(6-7): 497-507, 2014 Oct.
Article En | MEDLINE | ID: mdl-25117514

GPI2 encodes for one of the six accessory subunits of the GPI-N-acetylglucosaminyltransferase (GPI-GnT) complex that catalyzes the first step of GPI biosynthesis in S. cerevisiae and C. albicans. It has been previously reported in S. cerevisiae that this subunit physically interacts with and negatively modulates Ras signaling. On the other hand, studies from our lab have shown that the homologous subunit in C. albicans is a positive modulator of Ras signaling. Are the functions of this subunit therefore strictly species dependent? We present here functional complementation studies on GPI2 from S. cerevisiae and C. albicans that were carried out to address this issue. Expression of CaGPI2 in a ScGPI2 conditional lethal mutant could not restore its growth defects. Likewise, ScGPI2 overexpression in a CaGPI2 heterozygous mutant could not restore its deficient GPI-GnT activity or reverse defects in its cell wall integrity and could only poorly restore filamentation. However, interestingly, ScGPI2 could restore lanosterol demethylase (CaERG11) levels and reverse azole resistance of the CaGPI2 heterozygote. It appeared to do this by regulating levels of another GPI-GnT subunit, CaGPI19, which we have previously shown to be involved in cross-talk with CaERG11. Thus, the effect of CaGPI2 on sterol biosynthesis in C. albicans is independent of its interaction with the GPI-GnT complex and Ras signaling pathways. In addition, the interaction of Gpi2 with other subunits of the GPI-GnT complex as well as with Ras signaling appears to have evolved differently in the two organisms.


Candida albicans/metabolism , Glycosylphosphatidylinositols/metabolism , Membrane Proteins/metabolism , Saccharomyces cerevisiae Proteins/metabolism , Saccharomyces cerevisiae/enzymology , Amino Acid Sequence , Base Sequence , Biocatalysis , DNA Primers , Membrane Proteins/chemistry , Molecular Sequence Data , Saccharomyces cerevisiae Proteins/chemistry , Sequence Homology, Amino Acid
...